{"id":31206,"date":"2025-12-16T17:02:01","date_gmt":"2025-12-16T16:02:01","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=31206"},"modified":"2025-12-16T17:02:02","modified_gmt":"2025-12-16T16:02:02","slug":"la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/","title":{"rendered":"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l&#8217;AMR"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"324\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png\" alt=\"\" class=\"wp-image-31211\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png 1024w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-300x95.png 300w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-768x243.png 768w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2.png 1336w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p>L&#8217;autorit\u00e9 de pr\u00e9paration et de r\u00e9action aux urgences sanitaires de la Commission europ\u00e9enne s&#8217;attaque \u00e0 l&#8217;une des causes profondes de la r\u00e9sistance aux antimicrobiens en investissant dans des diagnostics rapides et en r\u00e9duisant l&#8217;utilisation inutile d&#8217;antibiotiques. En signant un contrat avec un consortium d&#8217;entreprises europ\u00e9ennes, <strong>la Commission europ\u00e9enne s&#8217;engage \u00e0 investir 8,85 millions d&#8217;euros dans le d\u00e9veloppement d&#8217;un dispositif de diagnostic r\u00e9volutionnaire qui aidera les cliniciens \u00e0 choisir le traitement le plus appropri\u00e9 pour les patients susceptibles d&#8217;avoir besoin d&#8217;antibiotiques<\/strong>.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-1 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/health.ec.europa.eu\/latest-updates\/commission-invests-eu885-million-innovative-diagnostics-combat-antimicrobial-resistance-2025-12-15_en\" target=\"_blank\" rel=\"noreferrer noopener\">Lire l&#8217;annonce officielle de la Commission europ\u00e9enne<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>L&#8217;autorit\u00e9 de pr\u00e9paration et de r\u00e9action aux urgences sanitaires de la Commission europ\u00e9enne s&#8217;attaque \u00e0 l&#8217;une des causes profondes de la r\u00e9sistance aux antimicrobiens en investissant dans des diagnostics rapides et en r\u00e9duisant l&#8217;utilisation inutile d&#8217;antibiotiques. En signant un contrat avec un consortium d&#8217;entreprises europ\u00e9ennes, la Commission europ\u00e9enne s&#8217;engage \u00e0 investir 8,85 millions d&#8217;euros dans [&hellip;]<\/p>\n","protected":false},"author":285,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31],"tags":[6697,6607,6733,6698,6623],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l&#039;AMR - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l&#039;AMR - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-16T16:02:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-16T16:02:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png\" \/>\n<meta name=\"author\" content=\"Aurore Brunet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Aurore Brunet\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/\"},\"author\":{\"name\":\"Aurore Brunet\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41\"},\"headline\":\"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l&#8217;AMR\",\"datePublished\":\"2025-12-16T16:02:01+00:00\",\"dateModified\":\"2025-12-16T16:02:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/\"},\"wordCount\":107,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png\",\"keywords\":[\"AMR\",\"Antibior\u00e9sistance\",\"Antibiotic Resistance\",\"Antimicrobial Resistance\",\"Financements\"],\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/\",\"name\":\"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l'AMR - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png\",\"datePublished\":\"2025-12-16T16:02:01+00:00\",\"dateModified\":\"2025-12-16T16:02:02+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l\u2019AMR\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41\",\"name\":\"Aurore Brunet\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l'AMR - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/","og_locale":"fr_FR","og_type":"article","og_title":"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l'AMR - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2025-12-16T16:02:01+00:00","article_modified_time":"2025-12-16T16:02:02+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png"}],"author":"Aurore Brunet","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Aurore Brunet"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/"},"author":{"name":"Aurore Brunet","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41"},"headline":"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l&#8217;AMR","datePublished":"2025-12-16T16:02:01+00:00","dateModified":"2025-12-16T16:02:02+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/"},"wordCount":107,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png","keywords":["AMR","Antibior\u00e9sistance","Antibiotic Resistance","Antimicrobial Resistance","Financements"],"articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/","name":"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l'AMR - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png","datePublished":"2025-12-16T16:02:01+00:00","dateModified":"2025-12-16T16:02:02+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/12\/Commission-Europeenne-8.85M-2-1024x324.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/la-commission-europeenne-investit-885me-dans-des-diagnostics-innovants-pour-lutter-contre-lamr\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"La Commission europ\u00e9enne investit 8,85M\u20ac dans des diagnostics innovants pour lutter contre l\u2019AMR"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6d6eef4984fc1159096f6dd1f6c2ac41","name":"Aurore Brunet"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-14 17:17:08","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31206"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/285"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=31206"}],"version-history":[{"count":1,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31206\/revisions"}],"predecessor-version":[{"id":31213,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/31206\/revisions\/31213"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=31206"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=31206"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=31206"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}